Click for best price
Histoplasmosis Treatment Market Size, Share 2022
Histoplasmosis is an infection that occurs from breathing spores of a fungus called Histoplasma capsulatum. Histoplasmosis is a fungal infection that occurs throughout the world. Histoplasma fungus grows as a mold in the soil. The soil that contains the droppings of bat or birds usually contains large amount of this fungus. The people with weakened immune system are usually more prone and increases the risk of being affected or reactivated with histoplasmosis. Usually people very young, old people and people affected with cancer, AIDS or organ transplant have severe symptoms. The people with chronic lung disease such as bronchiectasis or emphysema have high risk of severe pain. The common symptoms of histoplasmosis is fever, chills, cough, chest pain, red skin bumps, mouth sores etc. In some patients suffering from histoplasmosis may spread throughout the body and cause irritation and swelling in response to infection.
This report contains market size and forecasts of Histoplasmosis Treatment in Global, including the following market information:
Global Histoplasmosis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Histoplasmosis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Amphotericin B Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Histoplasmosis Treatment include Bristol Myers Squibb, Sigma tau pharmaceuticals Inc., Three rivers pharmaceuticals, Astellas pharma US Inc., Abbott laboratories, Abraxis pharmaceutical products, Teva parenteral medicines Inc. and X gen pharmaceuticals Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Histoplasmosis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Histoplasmosis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Histoplasmosis Treatment Market Segment Percentages, by Type, 2021 (%)
Amphotericin B
Itraconazole
Ketoconazole
Other
Global Histoplasmosis Treatment Market, by Distribution Channel, 2017-2022, 2023-2028 ($ millions)
Global Histoplasmosis Treatment Market Segment Percentages, by Distribution Channel, 2021 (%)
Hospitals Pharmacies
Drug stores and retail pharmacy
E-commerce
Other
Global Histoplasmosis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Histoplasmosis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Histoplasmosis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Histoplasmosis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol Myers Squibb
Sigma tau pharmaceuticals Inc.
Three rivers pharmaceuticals
Astellas pharma US Inc.
Abbott laboratories
Abraxis pharmaceutical products
Teva parenteral medicines Inc.
X gen pharmaceuticals Inc.
| Report Attributes |
Report Details |
| Report Title |
Histoplasmosis Treatment Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Histoplasmosis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Distribution Channel
1.3 Global Histoplasmosis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Histoplasmosis Treatment Overall Market Size
2.1 Global Histoplasmosis Treatment Market Size: 2021 VS 2028
2.2 Global Histoplasmosis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Histoplasmosis Treatment Players in Global Market
3.2 Top Global Histoplasmosis Treatment Companies Ranked by Revenue
3.3 Global Histoplasmosis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Histoplasmosis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Histoplasmosis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Histoplasmosis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Histoplasmosis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Histoplasmosis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Histoplasmosis Treatment Market Size Markets, 2021 & 2028
4.1.2 Amphotericin B
4.1.3 Itraconazole
4.1.4 Ketoconazole
4.1.5 Other
4.2 By Type - Global Histoplasmosis Treatment Revenue & Forecasts
4.2.1 By Type - Global Histoplasmosis Treatment Revenue, 2017-2022
4.2.2 By Type - Global Histoplasmosis Treatment Revenue, 2023-2028
4.2.3 By Type - Global Histoplasmosis Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Histoplasmosis Treatment Market Size, 2021 & 2028
5.1.2 Hospitals Pharmacies
5.1.3 Drug stores and retail pharmacy
5.1.4 E-commerce
5.1.5 Other
5.2 By Distribution Channel - Global Histoplasmosis Treatment Revenue & Forecasts
5.2.1 By Distribution Channel - Global Histoplasmosis Treatment Revenue, 2017-2022
5.2.2 By Distribution Channel - Global Histoplasmosis Treatment Revenue, 2023-2028
5.2.3 By Distribution Channel - Global Histoplasmosis Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Histoplasmosis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Histoplasmosis Treatment Revenue & Forecasts
6.2.1 By Region - Global Histoplasmosis Treatment Revenue, 2017-2022
6.2.2 By Region - Global Histoplasmosis Treatment Revenue, 2023-2028
6.2.3 By Region - Global Histoplasmosis Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Histoplasmosis Treatment Revenue, 2017-2028
6.3.2 US Histoplasmosis Treatment Market Size, 2017-2028
6.3.3 Canada Histoplasmosis Treatment Market Size, 2017-2028
6.3.4 Mexico Histoplasmosis Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Histoplasmosis Treatment Revenue, 2017-2028
6.4.2 Germany Histoplasmosis Treatment Market Size, 2017-2028
6.4.3 France Histoplasmosis Treatment Market Size, 2017-2028
6.4.4 U.K. Histoplasmosis Treatment Market Size, 2017-2028
6.4.5 Italy Histoplasmosis Treatment Market Size, 2017-2028
6.4.6 Russia Histoplasmosis Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Histoplasmosis Treatment Market Size, 2017-2028
6.4.8 Benelux Histoplasmosis Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Histoplasmosis Treatment Revenue, 2017-2028
6.5.2 China Histoplasmosis Treatment Market Size, 2017-2028
6.5.3 Japan Histoplasmosis Treatment Market Size, 2017-2028
6.5.4 South Korea Histoplasmosis Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Histoplasmosis Treatment Market Size, 2017-2028
6.5.6 India Histoplasmosis Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Histoplasmosis Treatment Revenue, 2017-2028
6.6.2 Brazil Histoplasmosis Treatment Market Size, 2017-2028
6.6.3 Argentina Histoplasmosis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Histoplasmosis Treatment Revenue, 2017-2028
6.7.2 Turkey Histoplasmosis Treatment Market Size, 2017-2028
6.7.3 Israel Histoplasmosis Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Histoplasmosis Treatment Market Size, 2017-2028
6.7.5 UAE Histoplasmosis Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Corporate Summary
7.1.2 Bristol Myers Squibb Business Overview
7.1.3 Bristol Myers Squibb Histoplasmosis Treatment Major Product Offerings
7.1.4 Bristol Myers Squibb Histoplasmosis Treatment Revenue in Global Market (2017-2022)
7.1.5 Bristol Myers Squibb Key News
7.2 Sigma tau pharmaceuticals Inc.
7.2.1 Sigma tau pharmaceuticals Inc. Corporate Summary
7.2.2 Sigma tau pharmaceuticals Inc. Business Overview
7.2.3 Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Major Product Offerings
7.2.4 Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Revenue in Global Market (2017-2022)
7.2.5 Sigma tau pharmaceuticals Inc. Key News
7.3 Three rivers pharmaceuticals
7.3.1 Three rivers pharmaceuticals Corporate Summary
7.3.2 Three rivers pharmaceuticals Business Overview
7.3.3 Three rivers pharmaceuticals Histoplasmosis Treatment Major Product Offerings
7.3.4 Three rivers pharmaceuticals Histoplasmosis Treatment Revenue in Global Market (2017-2022)
7.3.5 Three rivers pharmaceuticals Key News
7.4 Astellas pharma US Inc.
7.4.1 Astellas pharma US Inc. Corporate Summary
7.4.2 Astellas pharma US Inc. Business Overview
7.4.3 Astellas pharma US Inc. Histoplasmosis Treatment Major Product Offerings
7.4.4 Astellas pharma US Inc. Histoplasmosis Treatment Revenue in Global Market (2017-2022)
7.4.5 Astellas pharma US Inc. Key News
7.5 Abbott laboratories
7.5.1 Abbott laboratories Corporate Summary
7.5.2 Abbott laboratories Business Overview
7.5.3 Abbott laboratories Histoplasmosis Treatment Major Product Offerings
7.5.4 Abbott laboratories Histoplasmosis Treatment Revenue in Global Market (2017-2022)
7.5.5 Abbott laboratories Key News
7.6 Abraxis pharmaceutical products
7.6.1 Abraxis pharmaceutical products Corporate Summary
7.6.2 Abraxis pharmaceutical products Business Overview
7.6.3 Abraxis pharmaceutical products Histoplasmosis Treatment Major Product Offerings
7.6.4 Abraxis pharmaceutical products Histoplasmosis Treatment Revenue in Global Market (2017-2022)
7.6.5 Abraxis pharmaceutical products Key News
7.7 Teva parenteral medicines Inc.
7.7.1 Teva parenteral medicines Inc. Corporate Summary
7.7.2 Teva parenteral medicines Inc. Business Overview
7.7.3 Teva parenteral medicines Inc. Histoplasmosis Treatment Major Product Offerings
7.7.4 Teva parenteral medicines Inc. Histoplasmosis Treatment Revenue in Global Market (2017-2022)
7.7.5 Teva parenteral medicines Inc. Key News
7.8 X gen pharmaceuticals Inc.
7.8.1 X gen pharmaceuticals Inc. Corporate Summary
7.8.2 X gen pharmaceuticals Inc. Business Overview
7.8.3 X gen pharmaceuticals Inc. Histoplasmosis Treatment Major Product Offerings
7.8.4 X gen pharmaceuticals Inc. Histoplasmosis Treatment Revenue in Global Market (2017-2022)
7.8.5 X gen pharmaceuticals Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Histoplasmosis Treatment Market Opportunities & Trends in Global Market
Table 2. Histoplasmosis Treatment Market Drivers in Global Market
Table 3. Histoplasmosis Treatment Market Restraints in Global Market
Table 4. Key Players of Histoplasmosis Treatment in Global Market
Table 5. Top Histoplasmosis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Histoplasmosis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Histoplasmosis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Histoplasmosis Treatment Product Type
Table 9. List of Global Tier 1 Histoplasmosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Histoplasmosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Histoplasmosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Histoplasmosis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Histoplasmosis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Distribution Channel ? Global Histoplasmosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Distribution Channel - Histoplasmosis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Distribution Channel - Histoplasmosis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Histoplasmosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Histoplasmosis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Histoplasmosis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Histoplasmosis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Histoplasmosis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Histoplasmosis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Histoplasmosis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Histoplasmosis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Bristol Myers Squibb Corporate Summary
Table 31. Bristol Myers Squibb Histoplasmosis Treatment Product Offerings
Table 32. Bristol Myers Squibb Histoplasmosis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Sigma tau pharmaceuticals Inc. Corporate Summary
Table 34. Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Product Offerings
Table 35. Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Three rivers pharmaceuticals Corporate Summary
Table 37. Three rivers pharmaceuticals Histoplasmosis Treatment Product Offerings
Table 38. Three rivers pharmaceuticals Histoplasmosis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Astellas pharma US Inc. Corporate Summary
Table 40. Astellas pharma US Inc. Histoplasmosis Treatment Product Offerings
Table 41. Astellas pharma US Inc. Histoplasmosis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Abbott laboratories Corporate Summary
Table 43. Abbott laboratories Histoplasmosis Treatment Product Offerings
Table 44. Abbott laboratories Histoplasmosis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Abraxis pharmaceutical products Corporate Summary
Table 46. Abraxis pharmaceutical products Histoplasmosis Treatment Product Offerings
Table 47. Abraxis pharmaceutical products Histoplasmosis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Teva parenteral medicines Inc. Corporate Summary
Table 49. Teva parenteral medicines Inc. Histoplasmosis Treatment Product Offerings
Table 50. Teva parenteral medicines Inc. Histoplasmosis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. X gen pharmaceuticals Inc. Corporate Summary
Table 52. X gen pharmaceuticals Inc. Histoplasmosis Treatment Product Offerings
Table 53. X gen pharmaceuticals Inc. Histoplasmosis Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Histoplasmosis Treatment Segment by Type in 2021
Figure 2. Histoplasmosis Treatment Segment by Distribution Channel in 2021
Figure 3. Global Histoplasmosis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Histoplasmosis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Histoplasmosis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Histoplasmosis Treatment Revenue in 2021
Figure 8. By Type - Global Histoplasmosis Treatment Revenue Market Share, 2017-2028
Figure 9. By Distribution Channel - Global Histoplasmosis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Histoplasmosis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Histoplasmosis Treatment Revenue Market Share, 2017-2028
Figure 12. US Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Histoplasmosis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Histoplasmosis Treatment Revenue Market Share, 2017-2028
Figure 24. China Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Histoplasmosis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Histoplasmosis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Histoplasmosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Bristol Myers Squibb Histoplasmosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Three rivers pharmaceuticals Histoplasmosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Astellas pharma US Inc. Histoplasmosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbott laboratories Histoplasmosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Abraxis pharmaceutical products Histoplasmosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva parenteral medicines Inc. Histoplasmosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. X gen pharmaceuticals Inc. Histoplasmosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
